C162220Level 4
Axitinib/Pembrolizumab Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of axitinib and pembrolizumab that can be used for the treatment of renal cell carcinoma (RCC) and alveolar soft part sarcoma (ASPS).
**Synonyms:** - Axitinib and Pembrolizumab - Axitinib-Pembrolizumab - Axitinib/Pembrolizumab - Inlyta/Keytruda - Keytruda/Inlyta - Pembrolizumab-Axitinib - Pembrolizumab/Axitinib - Pembrolizumab/Axitinib Regimen
GET
/api/v1/systems/nci_thesaurus/nodes/C162220Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.